{
    "nctId": "NCT05743686",
    "briefTitle": "App for Adverse Events to Oral Chemotherapy - Pilot Study",
    "officialTitle": "Pilot Study of the Use of an App for the Follow-up of Oral Chemotherapy in Breast Cancer Patients",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Neoplasms, Chemotherapeutic Toxicity",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 28,
    "primaryOutcomeMeasure": "Number of calls",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* \\>=18 years of age\n* metastatic breast cancer\n* receiving oral chemotherapy (palbociclib, everolimus, or capecitabine)\n* possess an smartphone, a tablet, or a personal compiter\n\nExclusion Criteria:\n\n* cognitive impairments",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}